Nomic Bio, a Montreal-based proteomics company, is scaling its multiplexed protein assay platform through major industry research partnerships and software hiring. In November 2026, Machine Maker reported that Nomic Bio partnered with Parse Biosciences to construct Cascade, an AI-ready dataset comprising 100 million single cells to model the human immune response.
Cascade combines single-cell RNA sequencing profiles with secretome measurements produced by Nomic Bio's Omni 1000 platform, which profiles more than 1,000 secreted proteins across samples. The dataset captures cell responses to over 150,000 cytokine and drug perturbation conditions across multiple timepoints. Pharmaceutical companies including Pfizer, GSK, Sanofi, Graph Therapeutics, and Turbine have joined as foundational partners to leverage the multimodal data for predictive virtual cell modeling and drug target validation.
Expanding Proteomic Profiling Applications
Beyond immune modeling, Nomic Bio is integrating its proteomic technology into commercial fitness diagnostics. In October 2026, Yahoo Finance covered Nomic Bio's partnership with VO Health to power the Molecular Fitness Blood Test. The test uses Nomic Bio's Omni 1000 platform to measure over 1,000 proteins from a capillary blood sample, calculating an estimated VO₂ Max and generating pathway scores for inflammation, vascular function, and metabolism without requiring traditional maximal exercise equipment.
Founded in 2017 by Chief Executive Officer Milad Dagher and Head of Technology Jeff Munzar, Nomic Bio originated as Nplex Biosciences out of research at McGill University. The 24-person Series B+ company has raised $60.0 million in total funding from investors including Y Combinator, Lux Capital, SR One, Real Ventures, and Casdin Capital, including a $42 million Series B round highlighted by BetaKit.
Nomic Bio's platform addresses long-standing challenges in multiplex immunoassays. As detailed in Genetic Engineering and Biotechnology News, traditional ELISA multiplexing suffers from antibody cross-reactivity. Nomic Bio's proprietary nELISA technology pre-assembles capture and detection antibody pairs onto individual target-specific beads using DNA nanotechnology, keeping antibody reactions spatially separated. Using spectral barcoding with four fluorescent dyes, Nomic Bio generates up to 3,000 distinct bead codes readable on standard flow cytometers, bringing profiling costs down to $50 per sample with one-week turnaround times.
Engineering and Research Roles
To keep pace with partner demand and expand its data infrastructure, Nomic Bio is hiring for four roles across lab operations and software engineering.
In Montreal, the team is recruiting an onsite R&D Lab Associate. The role requires hands-on bench work to develop next-generation nELISA assays, working alongside Engineering R&D and Automation teams to execute large-scale experiments using liquid handlers and flow cytometers.
The company is also adding three remote engineering positions based in the United States to build out its data infrastructure and software stack:
- The
Data Engineerbuilds and scales data pipelines that transform flow cytometry data into quantitative protein measurements, while creating internal tools to support manufacturing quality control and profiling analysis. - The entry-level
Data Associateoperates and refines existing data pipelines, analyzing biochemical and molecular assay data to extract actionable insights for project teams. - The
Software Engineer (Jr to Sr Levels)develops core components of the nELISA software architecture, including internal laboratory information management systems (LIMS), data processing pipelines, web portals, and software interfaces for robotic lab automation equipment.
Open Roles at Nomic Bio
| Role | Location | Work Mode |
|---|---|---|
R&D Lab Associate |
Montreal | Onsite |
Data Engineer |
Remote (United States) / Remote (US) | Remote |
Data Associate |
Remote (United States) / Remote (US) | Remote |
Software Engineer (Jr to Sr Levels) |
Remote (United States) / Remote (US) | Remote |



